Evonik Industries recently announced that it plans to construct a new production plant for isophorone and isophorone diamine. A suitable site is being sought, and production is scheduled to start in 2013.

“Isophorone chemistry is a core business for Evonik,” said Klaus Engel, chairman of the Executive Board. “The market for isophorone and its derivatives is growing steadily and proved to be robust even during the economic crisis. That’s why we want to sustainably strengthen our market and technological leadership by capacity expansion.”

For additional details, visit www.evonik.com.